Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Biomarin Pharmaceutical Inc (BMRN)  
$88.63 1.44 (1.6%) as of 4:30 Fri 4/19


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 188,370,000
Market Cap: 16.70(B)
Last Volume: 1,778,607 Avg Vol: 1,398,026
52 Week Range: $76.22 - $99
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Drug Manufacturers - Other

Member Indexes:
    NASDAQ BIOTECHNOLOGY     NASDAQ COMPOSITE
    NASDAQ NNM COMPOSITE

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  811
Guru Rank Value     : 0.9
Guru Occurances    : 1

 

            6 Months   1 Year   2 Year  
 
Company Profile   BioMarin Pharmaceutical is a biotechnology company that develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Co.'s commercial products are Aldurazyme (laronidase) for Mucopolysaccharidosis I; Brineura (cerliponase alfa) for the treatment of late infantile neuronal ceroid lipofuscinosis type 2; Kuvan (sapropterin dihydrochloride) for the treatment of phenylketonuria; Naglazyme (galsulfase) the treatment of Mucopolysaccharidosis VI ; Palynziq (pegvaliase-pqpz) for adult patients with phenylketonuria; and Vimizim (elosulfase alpha) for the treatment of Mucopolysaccharidosis IV Type A.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 3,625
Total Buy Value $0 $0 $0 $314,469
Total People Bought 0 0 0 1
Total Buy Transactions 0 0 0 1
Total Shares Sold 139,229 182,993 316,353 638,922
Total Sell Value $12,316,080 $16,513,389 $28,948,007 $60,375,372
Total People Sold 5 5 6 8
Total Sell Transactions 11 15 24 57
End Date 2024-01-25 2023-10-24 2023-04-25 2022-04-25

   
Records found: 1213
  Page 10 of 49  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Meier Richard A Director   –       •      –    2013-02-19 4 AS $57.50 $287,500 D/D (5,000) 18,650     -
   Meier Richard A Director   –       •      –    2013-02-19 4 OE $16.92 $84,600 D/D 5,000 23,650     -
   Bienaime Jean Jacques Chief Executive Officer   •       •      –    2013-02-04 4 AS $55.77 $111,532 D/D (2,000) 153,691     -
   Bienaime Jean Jacques Chief Executive Officer   •       •      –    2013-02-04 4 OE $12.99 $25,980 D/D 2,000 155,691     -
   Bienaime Jean Jacques Chief Executive Officer   •       •      –    2013-01-23 4 AS $55.22 $220,880 D/D (4,000) 153,691     -
   Baffi Robert EVP, Technical Operations   •       –      –    2013-01-22 4 GA $0.00 $0 I/I 2,675 8,238     -
   Baffi Robert EVP, Technical Operations   •       –      –    2013-01-22 4 GD $0.00 $0 D/D 2,675 52,350     -
   Meier Richard A Director   –       •      –    2013-01-22 4/A AS $55.00 $275,000 D/D (5,000) 18,650     -
   Meier Richard A Director   –       •      –    2013-01-22 4/A OE $16.92 $84,600 D/D 5,000 23,650     -
   Bienaime Jean Jacques Chief Executive Officer   •       •      –    2013-01-22 4 AS $55.00 $550,000 D/D (10,000) 157,691     -
   Ajer Jeffrey Robert SVP, Chief Commercial Of   •       –      –    2013-01-22 4 AS $55.00 $165,000 D/D (3,000) 10,570     -
   Ajer Jeffrey Robert SVP, Chief Commercial Of   •       –      –    2013-01-22 4 OE $21.51 $64,530 D/D 3,000 13,570     -
   Wood Mark VP, Human Resources   •       –      –    2013-01-22 4 AS $54.81 $2,570,702 D/D (46,749) 25,646     -
   Wood Mark VP, Human Resources   •       –      –    2013-01-22 4 OE $14.39 $1,752,561 D/D 46,749 72,395     -
   Baffi Robert EVP, Technical Operations   •       –      –    2013-01-22 4 AS $55.00 $1,076,625 D/D (19,575) 100,413     -
   Baffi Robert EVP, Technical Operations   •       –      –    2013-01-22 4 OE $17.54 $343,346 D/D 19,575 119,988     -
   Bienaime Jean Jacques Chief Executive Officer   •       •      –    2013-01-18 4 AS $54.00 $270,000 D/D (5,000) 167,691     -
   Bienaime Jean Jacques Chief Executive Officer   •       •      –    2013-01-18 4 OE $12.99 $64,950 D/D 5,000 172,691     -
   Bienaime Jean Jacques Chief Executive Officer   •       •      –    2013-01-04 4 AS $52.24 $156,731 D/D (3,000) 167,691     -
   Bienaime Jean Jacques Chief Executive Officer   •       •      –    2013-01-04 4 OE $12.99 $38,970 D/D 3,000 170,691     -
   Baffi Robert EVP, Technical Operations   •       –      –    2013-01-03 4 AS $53.00 $1,060,000 D/D (20,000) 100,413     -
   Baffi Robert EVP, Technical Operations   •       –      –    2013-01-03 4 OE $17.54 $350,800 D/D 20,000 120,413     -
   Meier Richard A Director   –       •      –    2013-01-02 4 AS $50.00 $512,500 D/D (10,000) 18,650     -
   Meier Richard A Director   –       •      –    2013-01-02 4 OE $16.92 $169,200 D/D 10,000 28,650     -
   Bienaime Jean Jacques Chief Executive Officer   •       •      –    2012-12-31 4 AS $48.62 $243,116 D/D (5,000) 167,691     -
  1213 Records found
  Previous  10  11  12  13  14  15  16  17  18  19  Next   
  Page 10 of 49
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us